# Larimar Therapeutics, Inc.: Form 8-K, filed May 19, 2026

- Company: [Larimar Therapeutics, Inc.](/companies/lrmr.md) (CIK 1374690)
- Form: 8-K
- Filed: 2026-05-19
- Accepted by EDGAR: May 19, 2026, 16:27 ET
- Period: 2026-05-19
- Accession: 0001193125-26-230852
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1374690/000119312526230852/lrmr-20260519.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1374690/000119312526230852/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1374690/000119312526230852/lrmr-20260519.htm

Filed May 19, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-230852. Last ingested by Listed: Nov 13, 2026, 17:49 ET. No prices; not investment advice.
